Caricamento...
Absorption of riociguat (BAY 63-2521): bioavailability, food effects, and dose proportionality
Abstract. Riociguat (BAY 63-2521) is the first member of a novel class of compounds, the soluble guanylate cyclase (sGC) stimulators. Riociguat has a dual mode of action: it sensitizes sGC to endogenous nitric oxide (NO) and stimulates sGC independent of NO availability. To characterize the biopharm...
Salvato in:
| Pubblicato in: | Pulm Circ |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
University of Chicago Press
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4809663/ https://ncbi.nlm.nih.gov/pubmed/27096084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/685018 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|